Companies › VIVS

VivoSim Labs Inc (VIVS)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001497253 · EDGAR filings · Updated 2026-07-24

VivoSim Labs Inc (VIVS) has reported institutional ownership of 2.8%, with 24 institutional managers holding positions valued at $140.0K per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.

Filings this week (1)

• 2026-07-24 — Current report (8-K) filed

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

• 2026-07-17 — Current report (8-K) filed
• 2026-07-14 — Annual report (10-K) filed
• 2026-06-29 — Late-filing notice for annual report (NT 10-K)
• 2026-04-06 — SCHEDULE 13G filed
• 2026-04-03 — Current report (8-K) filed

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, VivoSim Labs Inc has 24 institutional holders and institutional ownership of 2.8%.

Insider activity

Insiders reported 6 transactions (0 buys, 1 sells) across 5 reporting insiders, with a net reported value of −$7.32K.

Data flags from SEC filings

Related companies

CURANEX PHARMACEUTICALS INC (CURX) · HCW Biologics Inc (HCWB) · SONOMA PHARMACEUTICALS INC (SNOA) · CHINA SXT PHARMACEUTICALS IN (SXTC) · Dermata Therapeutics Inc (DRMA) · Indaptus Therapeutics Inc (INDP)